Notice of AGM and Posting of Annual Report 2021

Accrol group

27/08/2021 13:32

RNS Number : 0613K

Accrol Group Holdings PLC

27 August 2021

 

 

27 August 2021

 

Accrol Group Holdings plc

("Accrol" or the "Group")

 

Notice of AGM and Posting of Annual Report 2021

 

Accrol Group Holdings plc, the UK's leading independent tissue converter, announces that its Annual Report for the year ended 30 April 2021, together with the Notice of its 2021 Annual General Meeting (AGM) are now available on the Group's website https://www.accrol.co.uk/investors/company-reports-presentations-and-circulars/ 

 

Copies of both documents will be posted to shareholders later today.

 

The AGM is to be held at the Group's registered office at Delta Building, Roman Road, Blackburn BB1 2LD at 10:00am on 24 September 2021.

 

 

For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman
Via Belvedere Communications
Gareth Jenkins, Chief Executive Officer
Richard Newman, Chief Financial Officer
Zeus Capital Limited(Nominated Adviser & Broker)
Dan Bate / Jordan Warburton
Tel: +44 (0) 161 831 1512
Dominic King / John Goold
Tel: +44 (0) 203 829 5000
Liberum Capital Limited (Joint Broker)
Tel: +44 (0) 20 3100 2222
Clayton Bush / Edward Thomas
Belvedere Communications Limited
Cat Valentine
Tel: +44 (0) 7715 769 078
Keeley Clarke
Tel: +44 (0) 7967 816 525
accrolpr@belvederepr.com

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate revenues totalling c.16% of the £2.1bn UK retail tissue market.

 

For more information, please visit www.accrol.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
NOALDLFLFVLLBBV